Dr. Lin on Chemoradiation in Elderly Patients with Esophageal Cancer

Steven H. Lin, MD, PhD
Published: Tuesday, Jan 31, 2017



Steven H. Lin, MD, PhD, associate professor at The University of Texas MD Anderson Center, discusses study of chemoradiation in elderly patients with esophageal cancer.

Many patients with esophageal cancer tend to be over 80 years of age. With the assumption that their age dictates their health, many physicians worldwide tend to veer away from aggressive therapies, such as chemoradiation, in fear of worsening toxicities and quality of life.

Surprisingly, elderly patients fared well with chemoradiation, with comparable toxicities to younger patients with the same disease. According to Lin, the baby-boomer generation is generally healthy and living longer than previous generations,which means aggressive treatment can and should be used when necessary.
 


Steven H. Lin, MD, PhD, associate professor at The University of Texas MD Anderson Center, discusses study of chemoradiation in elderly patients with esophageal cancer.

Many patients with esophageal cancer tend to be over 80 years of age. With the assumption that their age dictates their health, many physicians worldwide tend to veer away from aggressive therapies, such as chemoradiation, in fear of worsening toxicities and quality of life.

Surprisingly, elderly patients fared well with chemoradiation, with comparable toxicities to younger patients with the same disease. According to Lin, the baby-boomer generation is generally healthy and living longer than previous generations,which means aggressive treatment can and should be used when necessary.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x